For research use only. We do not sell to patients.
DCPLA-ME
CAS No. : 56687-67-3
Biological Activity:DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases.
Research Area:Neurological Disease
Targets:PKC
Related Screening Libraries:Bioactive Compound Library Plus;Epigenetics Compound Library;Kinase Inhibitor Library;TGF-beta/Smad Compound Library;Lipid Compound Library;Oxygen Sensing Compound Library;Cytoskeleton Compound Library;Neurodegenerative Disease-related Compound Library;Targeted Diversity Library;Coagulation and Anti-coagulation Compound Library;
Related Small Molecules:[Ala107]MBP(104-118) TFA;BJE6-106;Myelin Basic Protein;Staurosporine;PKC-iota inhibitor 1;Hypericin;Malantide;PKCiota-IN-2 formic;PF-4950834;C8 Dihydroceramide;SC-9;DL-erythro-Dihydrosphingosine;Safingol;ZIP;Psychosine-d5;TPPB;Enzastaurin;Protein Kinase C (19-31);Protein kinase inhibitor H-7 dihydrochloride;Teleocidin A1;Ro 31-8220;[Ser25] Protein Kinase C (19-31);CGP60474
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use;
- Structurally and synthetically diverse biologically active compounds;
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.;
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.;
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.;
- Customized order volume ranging from milligrams to kilograms scale;
Structurally and synthetically diverse biologically active compounds;
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.